Key result
Pre-diabetes and type 2 diabetes were associated with increased epicardial adipose tissue volume (146.6 ml vs 104.9 ml) and reduced attenuation (-72 HU vs -69 HU) compared to normal glucose tolerance, but these associations were not independent of visceral adipose tissue.
Why the study?
Data on epicardial adipose tissue volume and attenuation patterns in pre-diabetes are scarce, and their independent roles in pre-diabetes and T2D development remain unproven due to co-variation with anthropometrics.
Are pre-diabetes and type-2 diabetes associated with changes in epicardial adipose tissue volume and attenuation independently of other anthropometrics?
Cross-Sectional (n=1,948)
No
Are pre-diabetes and type-2 diabetes associated with changes in epicardial adipose tissue volume and attenuation independently of other anthropometrics?
While epicardial adipose tissue volume increases and attenuation decreases in pre-diabetes and T2D, these changes are largely driven by co-variation with visceral adipose tissue rather than being independent disease markers.
Epicardial adipose tissue changes in pre-diabetes and type 2 diabetes are not independent of visceral adipose tissue; leaves open their value as distinct markers.
Background The volume of epicardial adipose tissue (EATV) is increased in type-2 diabetes (T2D), while its attenuation (EATA) appears to be decreased. Similar patterns have been suggested in pre-diabetes, but data is scarce. In both pre-diabetes and T2D, any independent role of EATV and EATA in disease development remains to be proven, a task complicated by their substantial co-variation with other anthropometrics (e.g. BMI, waist circumference, and abdominal visceral adipose tissue (VAT). Method EATV and EATA was quantified in computed tomography (CT) images in a population study (n = 1,948) using an automatic technique. Data was available on BMI, waist circumference, abdominal visceral adipose tissue (VAT) area, insulin resistance (IR) and glucose tolerance, the latter ranging from normal (NGT), over pre-diabetes (impaired fasting glucose [IFG, n = 414] impaired glucose tolerance [IGT, n = 321] and their combination [CGI, n = 128]), to T2D. Results EATV was increased in pre-diabetes, T2D and IR in univariable analyses and when adjusting for BMI, however not when adjusting for waist or VAT. EATA was reduced in prediabetes, T2D and IR in univariable analyses and when adjusting for BMI and waist, however not when adjusting for VAT. Adjustment for other co-variates had little influence on the results. Conclusion EATV is increased and EATA reduced in pre-diabetes, T2D and IR, however, significant co-variation with other anthropometrics, especially VAT, obscures their function in disease development. The current results do not exclude a pathophysiological role of epicardial fat, but future studies need to adjust for anthropometrics, or focus on the microenvironment within the pericardial sac.
No takes yet. Share an insight, caveat, or question.
Molnár et al. (2022) conducted a cross-sectional in Pre-diabetes and Type 2 Diabetes (n=1,948). Pre-diabetes and Type 2 Diabetes vs. Normal glucose tolerance was evaluated on Epicardial adipose tissue volume (EATV) and attenuation (EATA). Pre-diabetes and type 2 diabetes were associated with increased epicardial adipose tissue volume (146.6 ml vs 104.9 ml) and reduced attenuation (-72 HU vs -69 HU) compared to normal glucose tolerance, but these associations were not independent of visceral adipose tissue.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: